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Secondary analysis of ChIP-SEQ dataset and genomic interactions of ICER

Abstract
The Inducible cyclic AMP (cAMP) Early Repressor (ICER) is an endogenous
transcriptional repressor of the cAMP-mediated signaling gene transcription pathway and
belongs to the CRE-binding protein (CREB)/CRE modulator (CREM) gene family. ICER
is associated to many functions and biological processes in the immune system, brain,
regulation of spermatogenesis, circadian control of transcription, apoptosis and metabolic
functions, and of particular interest, has been shown to act like a tumor suppressor. Recent
findings from our laboratory suggest that ICER might have a role in DNA repair, but further
experiments need to be performed. In this research, we aimed to elucidate the function of
ICER and its role in DNA repair, by first re-analyzing ICER’s DNA binding sites and
genome interaction from a recently published Chromatin Immunoprecipitation - Seq
dataset by Seidl et al, 2020. Then, using PCR and EMSA we empirically showed that ICER
binds to some important genes thought to be involved in variety of DNA Repair pathways
such as PARP1, RAD51C, XRCC6 and XRCC2, suggesting that ICER might play a role
in DNA repair mechanisms. These results are important and will inform future experiments
to understand ICER’s function in DNA repair.
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Introduction
Transcription is a highly regulated process controlled not only by an array of
regulatory proteins but also regulatory sequences. Proteins that regulate transcription
respond to various signaling pathways, such as the cAMP (cyclic Adenosine
Monophosphate) dependent system (Lee et al., 1995). The intracellular concentration of
the secondary messenger cAMP in different cell types is essential for the activation or
inhibition of transcription of many genes, and in doing so is involved in regulating many
physiological and pathological processes (Zhang et al., 2020). Two protein members of
this pathway that are important for gene regulation are CREM (cAMP Response Element
Modulator) and CREB (cAMP Response Element Binding protein). Both of these proteins,
together with AFT1 (Activator Transcription Factor 1), belong to a class of nuclear
transcription factors called the CREB family and respond to a specific palindromic
regulatory sequence composed of eight nucleotides: TGACGTCA, denominated CRE
(cAMP Response Element). Although variations on this motif exist, almost every CRE
contains at least a conserved half sequence (TGACG/CGTCA) (Lonze & Ginty, 2002).
cAMP responsive proteins are structurally similar; they are characterized by the
presence of a highly conserved basic leucine zipper (bZIP) domain: an α-helical coiledcoil structure with an adjacent basic domain located at the C-terminus, that facilitates DNA
binding and dimerization with other bZIP family members (Servillo et al., 2002). They also
have a Kinase Inducible Domain (KID) which contains a Serine within the Protein Kinase
A (PKA) phosphorylation site (RRPSY) (Zhang et al., 2020), located between two
glutamine rich domains (Q1 and Q2) that constitute the transcriptional activation domain
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(Xiao et al., 2010). The functional domains of CREB, CREM and ICER are shown on
Figure 1.
Figure 1
Structure of CREB and CREM showing the Activation and DNA binding domains and the
Serine residues phosphorylated by activating protein kinases. ICER structure is also
illustrated.

Note: Image adapted from Servillo et al, 2002

The CREB and CREM genes are complex and encode extensive homologous
proteins with activating or suppressing functions as a result of alternative splicing (Molina
et al., 1993) (Ortega-Martínez, 2015). The CREB gene produces only activator isoforms,
whereas CREM can produce isoforms that are either activators or repressors, depending on
the exons transcribed (Sassone-Corsi, 1995)
The CREM gene encodes more than 20 isoforms due to alternative promoter usage
and alternative splicing (29 isoforms reported on Uniprot ("UniProt: the universal protein
knowledgebase in 2021," 2021)) (Rauen et al., 2013) (Figure 2). Promoter 1 (P1) is located
in the upstream region of the CREM gene and is constitutively active. The KID, located in
the central region, is encoded by exons E and F. This domain interacts with coactivators
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such as the histone acetyltransferases CREB Binding Protein (CBP) and P300 and mediates
cAMP inducibility (Daniel et al., 2000). Exon C and the 3′-region of exon B encodes the
upstream glutamine-rich trans-activation domain Q1 (also named τ1) and exon G encodes
the downstream domain Q2 (τ2). Additionally, the CREM gene contains two DNA-binding
or dimerization domains (bZIP structure) encoded by exons H and I. Interestingly, exon I,
which has two alternative splice sites including the 3′-untranslated region (UTR) gives rise
to two DNA-binding domains (DBD1 and DBD2) but only one is included in the final
protein (Daniel et al., 2000) (Borlikova & Endo, 2009).
Figure 2
Schematic representation of the human CREM gene structure depicting exons and
promoters.

Note: Image adapted from Don et al, 2002
CREMα, CREMβ and CREMγ spliced isoforms originate from P1 and act as
antagonists (suppressors) of cAMP induced transcription (Foulkes et al., 1991), these
isoforms lack both glutamine rich (Q1 and Q2) domains important for the transactivation
function (Don & Stelzer, 2002). CREMτ, CREMτ1, CREMτ2 isoforms originate from the
same promoter (P1) as the suppressor isoforms, but in contrast to them, these isoforms act
as transcriptional activators and include the glutamine rich-domains in their sequence (Don
& Stelzer, 2002) (Foulkes et al., 1992). Two additional isoforms termed CREMθ1 and
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CREMθ2 are product of two exons (θ1 and θ2) containing two CREM alternative
promoters (P3 and P4 respectively). These two promoters are also cAMP responsive, and
can regulate the transcription of trans-activator forms of CREM when activated by a
cAMP-dependent protein kinase signaling (Daniel et al., 2000).
ICER (Inducible cAMP Early Repressor), a particular isoform of the CREM gene,
is generated by an alternative promoter, P2, located within an intron near the 3’ end of the
CREM gene. ICER is actually defined as a family of small 12-13 kDa proteins that lack
the transactivation and KID domain but contain the DBD (bZIP structure) that allows for
DNA binding and dimerization with CREM and CREB proteins (Molina et al., 1993).
ICER acts as a powerful transcriptional repressor and is induced by cAMP on its own
promoter. ICER expression is activated by transcriptional activators (e,g CREB/CREM)
that bind to P2, which contains four closely spaced CREs termed CAREs (cAMP
Autoregulatory Elements). This activation increases ICER’s intracellular concentration
and leads to a strong repression of cAMP-induced transcription of CRE-containing genes,
and negatively regulates ICER’s own expression by binding to its own promoter (Molina
et al., 1993) (Yehia, Schlotter, et al., 2001).
Due to alternative splicing, ICER transcript generates four isoforms called ICER I,
ICER Iγ, ICER II, and ICER IIγ (Figure 3). DBD1 and DBD2 are present on ICER I and
ICER II respectively and exon γ is absent on the γ isoforms (ICER Iγ and ICER IIγ)
(Sassone-Corsi, 1995). Another inducible isoform called small ICER (smICER) was
recently described in 2014 by Seidl et al. (Seidl et al., 2014). This isoform is generated by
a CRE-dependent internal promoter (P6) and is structurally similar to ICER but lacks the
ICER-specific exon and contains the γ domain (exon x) and one of the DBD. Its function
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is not well defined but it was shown to be induced after β-adrenergic stimulation in the
heart and researchers suggest that it could be responsible for the biological functions
attributed to ICER alone and is possibly present beyond the cardiac tissue (Seidl et al.,
2020).
Figure 3
Organization of ICER gene and structure of ICER isoforms.

Note: Image adapted from Borlikova et al, 2009.

ICER is associated with many functions and biological processes in the immune
system (Bodor et al., 2007) (Vaeth et al., 2011), brain (Borlikova & Endo, 2009) (Porter et
al., 2008), regulation of spermatogenesis (Don & Stelzer, 2002), circadian control of
transcription (Stehle et al., 1993), apoptosis (Tomita et al., 2003), metabolic functions
(Favre et al., 2011), and of particular interest, its role as a tumor suppressor gene product.
Studies have shown that ICER repressed the expression of growth controlling genes such
as c-fos and cyclin A, and inhibited the DNA synthesis and growth of human
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choriocarcinoma and pituitary tumor cells, by mediating cAMP antiproliferative activity
(Razavi et al., 1998). ICER forced expression inhibited cell growth of prostate cancer cell
lines LNCaP, reversed their transformed phenotype and arrested cells at the G1 phase of
the cell cycle (Mémin et al., 2002) (Yehia, Razavi, et al., 2001). Additionally, exogenous
ICER expression in leukemia cell line HL60, potentially repressed leukemia in vitro and
controlled tumor progression (Pigazzi et al., 2008).
Although these studies highlight the importance of ICER expression in the
regulation of cell growth, they have also revealed that significantly lower levels of ICER
protein, are not only present in some primary prostate tumors cells (Yehia, Razavi, et al.,
2001), but are also linked with melanomagenesis (Healey et al., 2013) and acute leukemia
(Pigazzi et al., 2008). Researchers demonstrated that in cancer cells, ICER mRNA levels
remained relatively unaltered when compared to ICER protein levels, thus suggesting that
this down-regulation was in fact the result of post-translational modifications targeting
ICER for proteasomal degradation (Folco & Koren, 1997) (Yehia, Schlotter, et al., 2001)
(Mémin et al., 2011) (Healey et al., 2013) (Cirinelli et al., 2022).
Selective targeting of the ubiquitin – proteasome pathway to destroy ICER at a high
rate, negatively affects its stability and transcriptional repressor functions. In cancer cells,
it has been shown that the level of ICER protein concentration is regulated by two
mechanisms: phosphorylation and/or ubiquitination. Yehia et al, (Yehia, Schlotter, et al.,
2001) revealed that the activation of the Mitogen Activated Protein Kinase (MAPK)
pathway, increased ICER phosphorylation at Serine 41 and targeted ICER for
ubiquitination; Mémin et al, (Mémin et al., 2011) presented evidence that ICER is
phosphorylated by the Cdk1/cyclinB mitotic kinase complex and then gets ubiquitinated
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during the cell cycle, and most recently, Cirinelli et al. (2022), determined that ICER gets
ubiquitinated in response to the Ac/N-end rule pathway by the E3 ubiquitin protein ligase
UBR4. This protein recognizes the acetylated N-terminus sequence of ICER for
polyubiquitination and mediates ICER proteasomal degradation in human melanoma cells.
Contrary to this, when the MAPK pathway was inhibited by cAMP in choriocarcinoma
and pituitary tumor cells, it stabilized ICER protein and prevented its phosphorylation and
degradation (Yehia, Schlotter, et al., 2001).
The aforementioned MAPK cascade plays a key role in cell proliferation, differentiation,
survival and death (Zhang & Liu, 2002). Cross-communication of this pathway with other
signaling cascades in the cells, such as cAMP, is crucial for regulation of cell proliferation
and help us understand its association with cancer and other diseases (Dhillon et al., 2007).
Mutations in this cascade are frequent and they are linked to cancer development and
progression, especially those affecting the RAS-RAF-MEK-ERK pathway, a very
important component of the MAPK signaling pathway controlling survival and
development of tumor cells (Guo et al., 2020). One link between ICER and the RAS-RAFMEK-ERK pathway has been previously demonstrated by Healey et al, (Healey et al.,
2013) who determined that ICER gets targeted for proteosomal degradation in human
tumors where RAS is mutated, leading to melanoma tumorigenesis, whereas inhibition of
RAS activity or the proteasome, rescued ICER from being degraded. Taken together, more
studies are needed for in-depth understanding of the impact that post translational
modifications and subsequent degradation of ICER have on these diseased states.
It has been hypothesized that ICER might be involved in DNA repair mechanisms
and that its expression is up-regulated in response to DNA damage caused by UV light;
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experiments performed at Dr. Molina’s laboratory showed that upon UV exposure and
subsequent DNA damage, ICER gets accumulated and also gets phosphorylated by the
DNA-dependent Protein Kinase (DNA-PK), an important protein in the DNA damage
response, DNA repair machinery and genome integrity maintenance (Goodwin &
Knudsen, 2014), however more evidence is needed to support this hypothesis. DNA
mutations and damage occur often from all the endogenous and exogenous agents that not
only cause genomic instability, but also interfere with important biologicals processes such
as DNA replication and transcription. To compensate for the damage, cells have developed
mechanisms that senses the damage and mediates its repair called the DNA Damage
Response (Dexheimer, 2013). If this response is perturbed, the DNA repair capacity will
be reduced and the accumulated mutations will lead to tumor development (Helleday et al.,
2008). There are five main DNA repair pathways: base excision repair (BER), mismatch
repair (MMR), nucleotide excision repair (NER), and double-strand break repair, including
both homologous recombination (HR) and non-homologous end joining (NHEJ)
(Dexheimer, 2013). Each mechanism will correct specific lesions and will be performed
by specific genes associated to it.
To better understand ICER’s biological function, this research focused on ICER’s
genomic DNA binding to help elucidate its role in the DNA damage response processes.
The research recently published by Seidl et al., (2020), provided a list of the DNA binding
sites of ICER and smICER obtained through ChIP-SEQ using ICER-HA and smICER-HA
constructs over-expressed in HEK-293 cells. HA-tags (Human Influenza Hemagglutinin
tags) are immunoreactive polypeptides attached to a protein of interest for its separation,
isolation, purification and detection (Zhao et al., 2013). Since ICER is a very small protein,
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the use of affinity tags such as HA-tags is very common due to the difficulties of producing
antibodies targeting ICER specifically. HA- tags are small in size and unlikely to interfere
with the functions or reactivity of ICER as demonstrated by previous experiments.
(Cirinelli et al., 2022).
A broad analysis of ICER and smICER DNA binding locations was performed and
after a comprehensive examination of the supporting dataset, it was possible to determine
that ICER interacts with essential DNA repair associated genes. Next, we took the
information from the in-silico analysis and verified these interactions in a skin cancer cell
line, via Polymerase Chain Reaction (PCR) and Electrophoretic Mobility Shift Assay
(EMSA). Confirmation of interactions in Melanoma cell line was important because
secondary analysis of genes originating from the previously published ChIP-SEQ data used
polyclonal antibodies for the pull-down possibly resulting in non-specific binding. They
also used Human Embryonic Kidney (HEK293) cells; a type of cell lines derived from a
human fetus that are widely used for the expression of proteins. These types of cells are
not likely to contain somatic mutations and were possibly different from the skin cancer
line we were interested in.
This study provides tremendous value to better understand ICER’s biological
function and minimize the lack of information regarding ICER’s role in the regulation of
important genes associated to DNA repair pathways, because a similar process can be
replicated for other biological functions of interest.
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Materials and methods
Identification of ICER/SmICER interacting genes and function
Seidl et al., (2020) provided a supplementary Excel spreadsheet containing ChIPSEQ data of validated ICER genome-wide binding locations from the ICER-HA and
smICER-HA constructs overexpressed in HEK293 cells. The information from the
spreadsheet contained the Gene ID, Gene Symbol, genomic coordinates, and relationship
to the expected transcriptional start site (TSS). This information was categorized based on
Gene Ontology (GO) annotations by using a batch query via UniProt Knowledgebase.
(Dimmer et al., 2012). This provided relevant information such as related biological
functions for all the genes in this dataset.
Genes located upstream of the TSS region at which ICER, smICER and both were
binding were grouped according to related biological processes as defined by their Gene
Ontology terms. However, some genes have implications in many biological processes. To
facilitate the sorting and grouping based on Biological Function, a Macro program was
created in Microsoft Excel to automatically search and display all the genes that match a
given search term entered via a drop down. In this program 47,200 Biological Processes
terms can be queried against the gene list from the Seidl et al., 2020 paper. Matching terms
were exported to a new sheet which reduced search time and also allowed for easy
comparison against similar functions. The list was filtered for different key functions such
as Apoptosis, DNA damage and DNA repair and tables containing the genes that have
reported those biological functions were obtained for analysis. Genes that matched “DNA
Repair” were selected for investigational purposes. The coordinates of candidate genes
involved in DNA Repair that were shown to bind upstream of the TSS were converted to
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an interval file through Galaxy (Afgan et al., 2018), based on hg19. Sequences were then
manually inspected using the UCSC genome browser, to confirm the presence of CRE’s in
the selected genomic coordinates.
While it is likely that smICER also inhibits transcription by binding to CRE’s, there
were some smICER specific gene targets pulled down by ChIP-SEQ. These discrepancies
were not previously addressed by the group that published the initial ChIP-SEQ dataset.
To investigate if there were any other potentially relevant regulatory regions or sites in
smICER, sequences from this secondary analysis were examined using MEME-ChIP motif
analysis (Bailey et al., 2015). Shared genes by both ICER and smICER, known to contain
full canonical CRE’s half CRE’s or no CRE’s were also analyzed using MEME ChIP and
Galaxy as a control.
Polymerase Chain Reaction
PCR was carried out using Chromatin immunoprecipitated (ChIP) DNA after
transfection of Human melanoma cells SK-MEL-24 (ATCC® HTB-71™) with HA-tagged
ICER. Cells were obtained from ATCC and cultured in Eagle’s Minimum Essential
Medium (EMEM) with 15% Heat inactivated FBS) and 5mL of Penicillin/Streptomycin.
pcDNA3.1™(+) plasmids were used for ICER-Iɣ expression with HA-tag on N or Cterminus. Chromatin Immunoprecipitation was performed according to manufacturer
protocol using Simple ChIP ® Enzymatic Chromatin IP Kit containing Magnetic beads.
ChIP grade polyclonal Anti-HA tag antibodies were obtained from ABCAM and used as
recommended by manufacturer.
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Primers were designed to be centered around the previously identified CRE(s), and
had a predicted amplicon between 150 and 200bp and GC content ~50% (Table 1) ChIP
DNA was sonicated to a fragment size ~150-900bp and so a smaller amplicon was
preferred to avoid missing the target loci. ChIP DNA was quantified using dsDNA HS
qubit assay kit (High-Sensivity double stranded DNA). Briefly, mix was prepared by
combining 199 μL of buffer with 1 μL of dye. 199 μL of buffer+dye was then combined
with 1 μL of ChIP-DNA. Measurements taken in triplicate and concentration for
normalization was based on average of the triplicate concentrations in ng/μL. ChIP DNA
was normalized to a concentration 0.5 ng/μL in nuclease free Molecular Biology Grade
water. Human male genomic DNA (Promega cat # G1471) and EGFP transfection controls
prior to pull down served as positive controls, and Nuclease-Free water was the No
Template Control (NTC).
Table 1
Primers designed for PCR
Name

Sequence

INTS3_Forward
INTS3_Reverse
PAGR1_Forward
PAGR1_Reverse
PARP1 Forward
PARP1_Reverse
RAD51C_Forward
RAD51C_Reverse
XRCC2_Forward
XRCC2_Reverse
JMY_Forward
JMY_Reverse
LIG3_Forward
LIG3_Reverse

5’ GAGACGGGGTTTCACCACGT 3’
5’GAGTGCATCACACAGGCACG 3’
5’ CAGGAGTTCAAGACCAGCCTCG 3’
5’CAGTGGCATGATCTTGGCTCAC 3’
5’ GTCGCCCATGTTTGATGGAAAAG 3’
5’GCCCCAGTATGTACACACCTGTC3’
5’GACTGCGCAAAGCTGCAAG 3’
5’CATTTCAAAGCGGAACGTCTTCC 3’
5’ GACAAGAAAAGCACCAGCTGTC 3’
5’GGAGCATGCGCAATAGGGTG 3’
5’TCAGCATCGCCACAATGTTGC 3’
5’TCAGGGGACGCCGAGAGGA 3’
5’GTGGCTAATTATGGGGCCTAACT 3’
5’GCCCAGTGACTTCAGCATTCTC 3’

Amplicon
size
193bp
193bp
176bp
176bp
185bp
185bp
174bp
174bp
144bp
144bp
152bp
152bp
203bp
203bp
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USP1_Forward
USP1_Reverse
POLB_Forward
POLB_Reverse

5’GTTCTCTCTGCCCGCACCA 3’
5’CGAGGGATGTAAAGGCATTCCC 3’
5’CTGGGCTGTCATTCTGAGGTGC 3’
5’GACCGGCGGAACAATGGTT 3’

20
185bp
185bp
197bp
197bp

PCR primers were synthesized by Eurofins and reconstituted to 100μM in TE buffer
(10mM Tris-HCl, 1mM EDTA; pH6.8) and PCR was performed according to KAPA HiFi
HotStart Ready Mix PCR Kit (KAPA Biosystems) protocol, containing KAPA HiFi
HotStart DNA Polymerase as follow: 5μl of ChIP DNA (as described above) was amplified
in total of 25 μL PCR reaction containing 1.5 μL of forward and reverse primers at 10μM
and 12.5 μL of 2x Kapa HiFi HotStart ReadyMix using the following program: 95 °C for
3 minutes; 35 cycles of 98 °C for 20 seconds, 63 °C for 15 seconds; and 72 °C for 30
seconds; and a final elongation at 72 °C for 1 minute. PCR products were visualized on a
2% (w/v) agarose gel. Confirmation of amplification of two genes with particular relevance
were visualized on an Agilent TapeStation 2200 using high sensitivity DNA tape.
Electrophoretic Mobility Shift Assay
For the supershift assay, IRD®700 end- labeled DNA oligonucleotides (Integrated
DNA Technologies, IA) containing the canonical CRE sequence and complementary
strand of each oligonucleotides without end-labeled IRDye (Integrated DNA technologies,
IA) were designed as shown in Table 2.
Table 2
Primers designed for EMSA
Name

Sequence

Scale

Purification

PARP1_Forward

/5IRD700/CCGGCACCCTGACGTTGAGGTGGAT

100nm

HPLC

PARP1_Reverse

/5IRD700/ATCCACCTCAACGTCAGGGTGCCGG

100nm

HPLC
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RAD51C_Forward

/5IRD700/CTTTACGTCTGACGTCACGCCGCAC

100nm

HPLC

RAD51C_Reverse

/5IRD700/GTGCGGCGTGACGTCAGACGTAAAG

100nm

HPLC

XRCC6_Forward

/5IRD700/ACATGCGTGATGACGTAGAGGGCGT

100nm

HPLC

XRCC6_Reverse

/5IRD700/ACGCCCTCTACGTCATCACGCATGT

100nm

HPLC

XRCC2_Forward

/5IRD700/GTTCCTGTGACGTCAGACTTCCGCG

100nm

HPLC

XRCC2_Reverse

/5IRD700/CGCGGAAGTCTGACGTCACAGGAAC

100nm

HPLC

Oligonucleotides were reconstituted to 100μM in TE buffer (10mM Tris-HCl, 1mM
EDTA; pH6.8) and annealed. Annealed oligonucleotides were diluted to 200nM and
Mobility shift assays were performed according to Odyssey infrared EMSA reagent Kit
(Li-COR Biosciences). 1μL of the purified protein was incubated with 2 μL of 10X Binding
Buffer (100 mM Tris, 500 mM KCl, 10 mM DTT; pH 7.5),1μL of poly dl.dC (1 μg/μl in
10 mM Tris, 1 mM EDTA; pH 7.5), 1μL of 100nM MgCl2, 1μL of double strand
oligonucleotides and 1 μL of anti HA-ICER for supershift determination for 20 min at room
temperature avoiding light in a 20 μL final volume reaction. After incubation, 2μL 10X
orange Loading Dye was added prior to electrophoresis. 22μL of binding reaction was
loaded onto a 5% polyacrylamide TBE gel at 100V for 1hr. The signal was detected using
the Li-Cor Odyssey Imaging system (LI-COR. Inc., USA).
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Results
Secondary analysis of ICER binding sites data set
ChIP-Sequencing supplementary data obtained from Seidl et al. (2020), revealed
2095 smICER and 1606 ICER binding sites, from which 1592 were found to be identical
between ICER and smICER, and the vast majority (32-35%) were located upstream of the
TSS (Seidl et al., 2020). A list with these genes was derived using UniProt Knowledgebase
and filtered to obtain the Gene Ontology (GO) biological functions. More than 1500 GO
terms were obtained representing the main processes and or related functions among the
genes and the number of appearances for each term. Using the GO term, it was possible to
link these terms to their more related term or “parent term” and group the most common
functions associated within them. Interestingly, DNA repair was one of the processes that
appeared into the first 30 GO terms, together with other well established ICERs functions
such as: transcription regulation, cell division, spermatogenesis and apoptosis. Table 3
displays the first 30 most common GO terms (“child” terms) associated with the genes and
their immediate GO Process ancestor (“parent” term).

Table 3
ICER and smICER upstream genes GO terms processes
Region

#counts of
GO terms

Upstream

34

Upstream

25

Upstream

19

Upstream

18

cell division

GO0051301

Upstream

14

regulation of transcription DNA-templated

GO0006355

GO term
positive regulation of transcription by RNA
polymerase II
regulation of transcription by RNA polymerase
II
positive regulation of transcription DNAtemplated

GO accession
ID number
GO0045944
GO0006357
GO0045893

GO process
ancestor
Biological
regulation
Biological
regulation
Biological
regulation
Cellular
Process
Metabolic
process
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Upstream

14

protein phosphorylation

GO0006468

Upstream

13

post-translational protein modification

GO0043687

Upstream

12

regulation of transcription by RNA polymerase
II

GO0006357

Upstream

12

spermatogenesis

GO0007283

Upstream

12

apoptotic process

GO0006915

Upstream

11

transcription by RNA polymerase II

GO0006366

Upstream

11

signal transduction

GO0007165

Upstream

11

regulation of signal transduction by p53 class
mediator

GO1901796

Upstream

10

RNA splicing

GO0008380

Upstream

10

protein ubiquitination

GO0016567

Upstream

10

protein polyubiquitination

GO0000209

Upstream

9

transcription initiation from RNA polymerase II
promoter

GO0006367

Upstream

9

protein transport

GO0015031

Upstream

9

protein stabilization

GO0050821

Upstream

9

protein deubiquitination

GO0016579

Upstream

9

protein autophosphorylation

GO0046777

Upstream

8

Upstream

8

Upstream

8

response to oxidative stress

GO0006979

Upstream

8

regulation of cell cycle

GO0051726

Upstream

8

protein folding

GO0006457

Upstream

8

MAPK cascade

GO0000165

Upstream

8

intracellular signal transduction

GO0035556

Upstream

8

DNA repair

GO0006281

negative regulation of transcription by RNA
polymerase II
retrograde vesicle-mediated transport Golgi to
endoplasmic reticulum

GO0000122
GO0006890

Metabolic
process
Metabolic
process
Biological
regulation
Reproductive
process
Cellular
Process
Metabolic
process
response to
stimulus
response to
stimulus
Metabolic
process
Metabolic
process
Metabolic
process
Metabolic
process
Localization
Biological
regulation
Metabolic
process
Metabolic
process
Biological
regulation
Localization
Response to
stimulus
Biological
regulation
Cellular
Process
Biological
regulation
Biological
regulation
Cellular
Process

Re-analysis of the list showed that the main functions to all those genes can be
linked to two main sources: Cell and Metabolic Processes; these terms are a broad
reference to all chemical reactions and pathways where compounds are formed as part of
the normal metabolic (anabolic and catabolic) processes carried out at the cellular level.
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It is clear that ICER, a transcription regulator and relevant member of the CREM
family, is interacting with genes taking part in critical processes such as: organic substance
metabolic processes (57.5%), primary metabolic processes (56.3%), cellular metabolic
processes (55.6%), nitrogen compound metabolic processes (42.7%) and biosynthetic
processes (37.5%). Table 4. shows the distribution of the functions discovered for the genes
at which both ICER and smICER bind.
MEME ChIP Motif analysis of the regulatory regions of ICER, smICER and shared
genes demonstrated that within a span of +/- 100bp from the central region of the
coordinates an a partial CRE motif (TGATGTCA) was present in the few genes at which
ICER alone was binding (Figure 4A). Interestingly, when the coordinates were uploaded
to MEME ChIP, no canonical CRE motif (full or half) was identified for the genes that
were specific to smICER DNA interactions (Figure 4B). To ensure we did not miss regions
that should contain a CRE, we expanded the span of the coordinates until we reached +/500bp from each side of the center peak, repeated the analysis and no CRE motif was
found. Finally, we uploaded the coordinates from the shared regions and a full canonical
CRE motif (TGACGTCA) was identified as the top-ranked motif among all the genes
(Figure 4C).
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Table 4
Upstream ICER and smICER GO terms and/or functions distribution.
GO TERM

COUNT

%

P-VALUE

BENJAMINI

275

57.5

1.50E-04

3.80E-03

269

56.3

2.60E-05

1.40E-03

266

55.6

7.00E-05

2.70E-03

204

42.7

6.10E-07

9.30E-05

178

37.2

1.30E-04

3.80E-03

171

35.8

5.10E-04

1.10E-02

166

34.7

1.80E-03

3.50E-02

88

18.4

2.60E-03

4.40E-02

84

17.6

4.80E-03

7.30E-02

75

15.7

1.00E-02

1.20E-01

Catabolic process

59

12.3

2.80E-02

2.30E-01

Cell cycle process

55

11.5

2.70E-05

1.40E-03

36

7.5

6.20E-03

8.60E-02

35

7.3

7.40E-03

9.40E-02

31

6.5

8.80E-02

6.40E-01

13

2.7

7.60E-02

5.70E-01

12

2.5

1.40E-02

1.40E-01

11

2.3

2.30E-02

2.20E-01

11

2.3

3.50E-02

2.80E-01

9

1.9

2.70E-02

2.30E-01

8

1.7

1.30E-02

1.40E-01

Organic
substance
metabolic process
Primary
metabolic process
Cellular
metabolic process
Nitrogen
compound
metabolic process
Biosynthetic
process
Regulation of
metabolic process
Cellular
component
organization
Cellular
component
biogenesis
Macromolecule
localization
Cellular
localization

Interspecies
interaction
between
organisms
Multi-organism
cellular process
Response to
abiotic stimulus
Methylation
Antigen
processing and
presentation
Multi-organism
metabolic process
Protein folding
Positive
regulation of
multi-organism
process
Modification of
morphology or
physiology of
other organism

GENES
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Figure 4
Discovered Motifs found by MEME using a +/- 100bp span from the middle of the peak on
the coordinates

Note: A) ICER, motif showing a partial CRE on. B). SmICER, NO canonical CRE
discovered, C). Shared genes, full canonical CRE found.

PCR demonstrated ICER interactions with genes related to repair pathways
We took the information from the in-silico analysis and focused on genes that
matched the gene search for DNA repair and downsized the list to a group of genes
involved in DNA repair pathways. Using ChIP DNA, we aimed to test a set of different
primers designed to amplify the putative CRE binding motif of NHA-ICER in the following
genes: INTS3, PAGR1, USP1, PARP1, POLB, LIG3, JMY, XRCC2 and RAD51C. Gel
electrophoresis results from the PCR assay revealed that most DNA fragments were
appropriately amplified for the genes of interest (Figure 5).

GENOMIC INTERACTIONS OF ICER

27

Figure 5
2% agarose gel Electrophoresis results from the PCR assay.

Number

Gene Name

1
2
3
4

INTS3
PAGR1
USP1
PARP1

5
6
7
8
9
10

POLB
LIG3
JMY
XRCC2
RAD51C
NTC

Predicted
Amplicon Size

193
176
185
185

197
203
152
144
174
0

Note: Bands represent the amplification of genes of interest on ChIP DNA from Human
melanoma cells SK-MEL-24 transfected with HA-tagged ICER. Ladders are located on the
right side of both gels. Lanes are described in the table below image.
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Bands 3 to 9 had positive results, suggesting that the genes USP1, PARP1, POLB,
LIG3, JMY, XRCC2 and RAD51 were pulled down via ChIP in SK-MEL-24 cells
following transient transfection with HA-ICER. Most bands were clear and run near the
200 bp in accordance with the predicted amplicon sizes (Figure 5). Bands 1 and 2
representing INTS3 and PAGR1 genes appeared smeared. This inadequate amplification
of the DNA fragments was probably due to primer design, sequence not present on the cell
type used or quality of sample and loading. No contamination or non-specific
amplifications were detected as shown in the No template Control (NTC).
We then prioritized those genes whose functions are of particular interest for future
studies and selected PARP1 and RAD51C to verify the data and confirm the proper
amplification of their products with a second PCR. TapeStation gel image (Figure 6) shows
the size and quality of the amplified DNA fragments. Lanes A1 to E1 correspond to PARP1
assays and lanes A2 to E2 to RAD51C assays. Lanes A1 and A2 show ChIP DNA
fragments that were bound to NHA-ICER with a size of 170-180bp as expected. Lane B2
represents ChIP DNA fragments bound to ICER-CHA having a similar size as NHA-ICER
+ RAD51C. Due to low yield, not enough ChIP DNA of ICER-CHA was obtained to test
it with PARP1 primers, and the assay had to be run with nuclease free water as seen in lane
B1. To assess for specificity, positive and negative controls were amplified. Lanes C1, C2,
D1 and D2 represent the positive controls. EGFP was effectively fragmented cell genomic
DNA prior to the immunoprecipitation (IP) step and was used as positive control together
with intact genomic DNA from Promega. Control fragments (170-190bp) are visible in
both lanes. Lanes E1 and E2 represent negative controls using nuclease free water.

GENOMIC INTERACTIONS OF ICER

29

Figure 6
TapeStation High Sensitivity DNA electrophoresis results.

Position
A1
B1

Description
NHA-ICER

+ PARP1
NTC + PARP1

C1
D1
E1
F1
A2
B2

EGFP + PARP1
Promega Genomic DNA + PARP1
NTC + PARP1
Blank
NHA-ICER + RAD51C
ICER-CHA + RAD51C

C2
D2
E2
F2

EGFP + RAD51C
Promega Genomic DNA + RAD51C
NTC + RAD51C
MWM

Note: A1, A2, B2: ChIP DNA amplification of genes PARP1 and RAD51C; C1, C2, D1,
D2: positive controls; E1, E2: negative controls; F2 lane: high Sensitivity ladder.
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ICER binds to genes involved in DNA repair pathways
To confirm that ICER’s interaction with the genome from the previously published
ChIP-SEQ data was specific, EMSA was carried out as described in materials and methods.
Seidl et al., (2020) used polyclonal antibodies in their procedures, and despite these being
used as the standard reagent for ChIP-Seq, they can lead to higher nonspecific background
and complex formations with nonspecific proteins (Busby et al., 2016). The use of
monoclonal antibodies, in contrast, offers the advantage of highly specific antibody –
antigen interactions and is highly recommended (DeCaprio & Kohl, 2017). For the immune
supershift assay, oligonucleotides were incubated with anti-HA-ICER, a specific
monoclonal antibody that recognizes the HA tag in the protein. Figure 7 displays the DNA
binding activity of ICER to four of the selected genes associated with DNA repair. Results
revealed that ICER could bind to the canonical CRE sequence present in PARP1, RAD51C,
XRCC2 and XRCC6 oligonucleotides as seen on lines 1,3,6 and 7, and this is confirmed
by the addition of anti-HA ICER that formed a complex and generated a distinct supershift
that appears clear in lines 2, 4, 6 and 8.
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Figure 7
EMSA analysis of ICER’s DNA binding activity with four genes related to DNA repair.

Note: The oligonucleotides contain the canonical CRE binding site. Lanes 1,3,5,7
correspond to the oligonucleotides; lanes 2,4,6,8 correspond to the oligonucleotides + antiHA ICER.

Since ICER is part of the CRE binding proteins that mediates gene expression, these
specific interactions between ICER and DNA repair associated genes are suggestive that
ICER could not only bind to all those genes with great affinity but most likely influence
their expression and/or activities within the cell.
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Discussion
Numerous studies have established a connection between ICER and cell
development, apoptosis, transcription regulation, antitumor properties and other functions
within the immune, nervous and neuroendrocrine system. Since ICER is an endogenous
transcriptional repressor that belongs to the CREB/CREM gene family, most of its effects
are mainly due to ICER’s expression in response to cAMP signaling cascade stimuli. While
the impact of ICER in acting as a tumor suppressor has been documented, more research
is needed to learn how ICER may contribute to reducing tumorigenesis in certain cancers.
In an attempt to better understand ICER’s function, a series of computational and
experimental approaches were carried out in this study to elucidate the impact of ICER in
DNA Repair.
ChIP-SEQ results from experiments performed by Seidl et al. (2020), demonstrated
that ICER and smICER were binding to a wide range of specific sites within the genome.
After a secondary analysis of the supplementary dataset, consisting of an extensive
examination and organization of the information provided, it was possible to retrieve a list
of interacting genes located upstream to the TSS and the functions associated to them using
the GO resource. The fact that processes such as, transcription regulation, cell division,
apoptosis and spermatogenesis appeared in the top 10 activities associated with ICER, was
no surprise, as those roles have been demonstrated in the past by several studies. Gene
ontology terms also revealed that Cell and Metabolic Processes are the molecular-level
activities at which ICER is mostly performing, this is in agreement with all the evidence
highlighting the various important functions that ICER has as a small nuclear
transcriptional repressor.
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ChIP-SEQ data revealed the presence of ICER and smICER shared binding sites as
well as some ICER specific targets. Interestingly, gene targets that where specific only for
smICER were also pulled down from the assay. We investigated these discrepancies further
to identify any other potentially regulatory regions or sites that were relevant for smICER
since this was not addressed by the authors. Using MEME-ChIP motif analysis, results
showed that within a span of +/- 100bp from the peak region of the coordinates for ICER
specific target genes, an almost full canonical CRE motif was found in the database as
expected (TGATGTCA). Similarly, a full putative CRE (TGACGTCA) was also found for
the shared genes as depicted in Figure 4, but no canonical full or half CRE was found in
the sequences at which smICER was specifically binding, even when the sequence length
was increased by hundreds of base pairs and the analysis was repeated.
smICER is a new isoform identified not long ago that gets regulated by a novel
intronic promoter (P6) within the CREM gene and differs from ICER in its structure (it
lacks exon X and the canonical N-terminus) (Seidl et al., 2014) but its biological function
is not yet well-defined. MEME-ChIP findings raised the question where is smICER binding
if is not binding to any full or half CRE? Despite that smICER is a slightly different protein,
it still contains the DNA binding domain needed to bind the CRE, hence it should be
behaving similarly to ICER protein and bind to the canonical motif instead of being
precipitated binding to a great number of genes that do not contain a full or even half CRE
motif. On the other hand, binding of smICER to a CRE located in another region and not
upstream of the gene, is less likely since these regulatory regions are typically located
within the promoter or enhancer regions.
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Contamination of DNA during the ChIP procedure or non-optimal conditions are
always contributors to the variability in the results and could be some of the reasons for the
inconsistencies. In addition to this, researchers ideally should have used specific
monoclonal antibodies instead of polyclonal antibodies to enrich the specific targeted
protein (and specific DNA region bound to it) during the immunoprecipitation. The use of
polyclonal antibodies probably yielded the very high background noise that resulted in a
great number of non-specific interactions between smICER and the genes pulled down
through ChIP. In future studies, it would be useful to experiment with monoclonal
antibodies to improve the quality, specificity and reproducibility of the results.
Interactions between ICER and the genome were found to be commonly occurring
among genes associated with apoptosis and DNA damage and repair processes. Since
recent evidence from the laboratory suggested that DNA damage could somehow be upregulating ICERs expression, it was of particular interest to find the “DNA repair” term
within the top 30 results on the obtained list. This was an important starting point to find
which specific genes ICER could be interacting with and continue exploring its possible
roles in this pathway. This also has considerable implications considering that in certain
tumors, ICER is targeted for degradation via ubiquitination. If ICER is degraded, then the
lack of transcriptional repression of these target genes are of great importance as future
drug targets in diseased states.
Because it has been previously publicized that ICER induces apoptosis (Ding et al.,
2005) (Cirinelli et al., 2022) we focused on studying ICER’s possible critical involvement
in DNA repair as a novel function. DNA repair is a very important process that mitigates
the effects of any mutagenic agent either inside or outside the cells that can lead to tumor
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development. Identification of the target genes of ICER as a transcription factor is relevant
for the understanding of its role in DNA damage and repair regulation. Genes such as
INTS3, PAGR1, USP1, PARP1, POLB, LIG3, JMY, XRCC2 and RAD51C play all
important roles in DNA repair pathways, either by forming protein complexes that promote
DNA repair or by conducting the repair itself. PCR results showed that amplification of
the CRE containing sequences of the targeted genes was successful for most of them,
(Figure 5) Although not all genes in this study could be verified to amplify correctly either
due to primer design or sequence not being present in the DNA extracted from human
melanoma cells, most PCR products had the expected size and demonstrated that designed
primers were suitable for future experiments as detected in the gel electrophoresis. Using
the TapeStation system, DNA fragments from PARP1 and RAD51C genes were amplified
and at the expected size. PARP1 (Poly (ADP-ribose) polymerase 1) is an ADP-ribosylating
enzyme important for mediating DNA repair response and is activated in response to DNA
base damage, DNA single-strand and double-strand breaks as well as in DNA maintenance
of genomic integrity (Kamaletdinova et al., 2019). RAD51C (RecA-like DNA recombinase
51-C) is a paralog of RAD51 gene and plays an important role in DNA double-strand break
repair via homologous recombination (HR) (Li et al., 2019).
In this context, the confirmation of these genomic interactions suggested that ICER
is somehow regulating the expression of these genes or the function of their protein
products. Additionally, these results are in agreement with the EMSA analysis, which
revealed that HA-ICER could bind the canonical CRE sequence present not only in PARP1
and RAD51C but other important genes associated with DNA repair such as, XRCC2 and
XRCC6. XRCC2 (X-ray Cross Complementing 2) is also a paralog of RAD51 and it is
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associated in the HR pathway by initiating recruitment of RAD51 proteins to the DNA
damage sites (Zhao et al., 2021). XRCC6 gene is an essential component of the NHEJ
pathway and it is involved in maintenance of genome integrity, hence important for
genome stability and cell survival (Bau et al., 2011) (Jia et al., 2015).
The mechanism by which ICER participates in the regulation of DNA repair genes
is an important topic for future research. PARP1 for example, one of the repair proteins of
interest, is a major target protein in breast and ovarian cancer treatments. Its
downregulation by PARP inhibitors (PARPi) results in a lack of DNA repair and therefore
cytotoxicity in tumor cells with mutated BRCA1/2 genes (Mateo et al., 2019). BRCA1 and
BRCA2 proteins play a critical role in the pathway of genome protection, and mutations in
these genes increase breast and ovarian cancer susceptibility (Patel et al., 2021). If there is
a defect in one DNA repair pathway, it can be compensated for by other pathway, for
instance, PARPi have been proposed as an effective treatment for this type of cancers since
they work under the concept of “synthetic lethality”, meaning that the loss of cell viability
is produced by the concomitant inactivation of two different genes: PARP1 and the already
dysfunctional BRCA1/2. Experiments focusing on understanding the mechanisms by
which ICER could be interacting with PARP1 and/ or regulating its mechanisms of action
on transfected ovarian cancer cells with and without BRCA1/2 mutations will provide
tremendous value to better understanding ICER’s biological function, because a similar
process can be replicated for other biological function of interest.
This study showed a novel correlation between ICER and DNA repair and provided
evidence that will serve as a basis for future research. Therefore, I strongly suggest
continuing experiments on different cell types and even using whole organisms to identify
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the target genes of ICER to help understand transcriptional networks and contribute to
elucidate ICER’s function and up-regulation in DNA damage response.
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